Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Monica Bertagnolli

Surgical Oncology · Harvard Medical School

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Jennifer Plichta

Breast Surgical Onc · Duke University

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    LB

    Dr. Linda Benavides

    Surgery · General Surgery
    Madigan Army Medical Center
    lindab

    Research

    Breaking point: Musculoskeletal combat injuries in Iraq, Afghanistan, and Syria—Epidemiology and future directions of care on the battlefield after over two decades of war

    2025

    Via The Journal of Trauma and Acute Care Surgery

    Research

    Committee on Surgical Combat Casualty Care position statement: Neurosurgical capability for the optimal management of traumatic brain injury during deployed operations

    2023

    Via The Journal of Trauma and Acute Care Surgery

    Research

    Hypocalcemia in Military Casualties From Point of Injury to Surgical Teams in Afghanistan

    2021

    Via Military Medicine

    Research

    Deployed skills training for whole blood collection by a special operations expeditionary surgical team

    2017

    Via The Journal of Trauma and Acute Care Surgery

    Research

    Surgical Instrument Sets for Special Operations Expeditionary Surgical Teams

    2017

    Via Journal of Special Operations Medicine

    Research

    The Golden Hour Offset Surgical Treatment Team Operational Concept: Experience of the 102nd Forward Surgical Team in Operation Freedom's Sentinel 2015–2016

    2017

    Via Journal of Special Operations Medicine

    Research

    Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines

    2011

    Via Expert Review of Vaccines

    Research

    AE37: a novel T-cell-eliciting vaccine for breast cancer

    2011

    Via Expert Opinion on Biological Therapy

    Research

    Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

    2011

    Via Cancer

    Research

    Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04

    2010

    Via Cancer

    Research

    Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial

    2010

    Via Journal of the American College of Surgeons

    Research

    Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

    2010

    Via Cancer

    Research

    Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide

    2010

    Via Vaccine

    Research

    Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate cancer patients

    2009

    Via Journal of the American College of Surgeons

    Research

    The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

    2009

    Via Clinical Cancer Research